The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.
about
Characterization of the major histocompatibility complex class II binding site on LAG-3 proteinThe three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chainCrystal structure of the complex between human CD8alpha(alpha) and HLA-A2Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitorsThe MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome.Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I.Human CD8 transgene regulation of HLA recognition by murine T cells.Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.Peptide binding by class I and class II MHC molecules.Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery.Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2.Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHCIdentification of the CD8 DE loop as a surface functional epitope. Implications for major histocompatibility complex class I binding and CD8 inhibitor design.
P2860
Q24323038-48270520-8DA3-4689-9F74-85990EEF69FAQ24563048-31B10964-BDD5-4486-BD6C-735909890A9FQ27738835-1401369F-8FED-4050-99D3-54BB2F1B4E12Q33183985-C73F906E-416D-4956-ACED-DD45B6C11011Q33878809-328259DE-6F79-4F81-8377-5471833F9BBCQ34719707-6D248887-912B-4EE3-87BA-8780E35243FEQ35824436-A8F0F9A9-BAF2-4514-BABA-CA0D22472B96Q36365379-063629C1-0852-4661-A03E-5CEBF84FF60BQ36365522-3C61B2C3-1E84-48D3-98E6-3EE9B3AD734DQ41417560-830647DA-A1DE-421C-8882-8899392B78DFQ41605278-20519F8E-AA61-46F5-A196-822CB6543530Q41753464-2D80BD9B-C2C5-4CBF-8B8C-036A89655A7BQ41991755-90D38908-A2D5-4170-90B4-BC66A4C3F16AQ42065609-4B28D5A5-939B-4486-A9E4-8F20AEDFFE43Q42411852-38A030F0-8FAD-46A2-A5E0-3E10D5CBBDD8Q47954431-D2D0407A-A496-419F-ABA1-EB1B7A5FB3E3
P2860
The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
The role of charge and multipl ...... support for a bivalent model.
@ast
The role of charge and multipl ...... support for a bivalent model.
@en
type
label
The role of charge and multipl ...... support for a bivalent model.
@ast
The role of charge and multipl ...... support for a bivalent model.
@en
prefLabel
The role of charge and multipl ...... support for a bivalent model.
@ast
The role of charge and multipl ...... support for a bivalent model.
@en
P2093
P2860
P356
P1476
The role of charge and multipl ...... support for a bivalent model.
@en
P2093
P A Giblin
P B Kavathas
P2860
P304
P356
10.1073/PNAS.91.5.1716
P407
P577
1994-03-01T00:00:00Z